Scott Giberson - 06 Jul 2022 Form 3 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Director
Signature
/s/ Ilan Katz, attorney-in-fact
Issuer symbol
SABS
Transactions as of
06 Jul 2022
Net transactions value
$0
Form type
3
Filing time
13 Jul 2022, 17:56:48 UTC
Next filing
15 Sep 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.